MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers.
Srinivasan G, Williamson EA, Kong K, Jaiswal AS, Huang G, Kim HS, Schärer O, Zhao W, Burma S, Sung P, Hromas R.
Srinivasan G, et al. Among authors: zhao w.
Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17438-17443. doi: 10.1073/pnas.1903150116. Epub 2019 Aug 8.
Proc Natl Acad Sci U S A. 2019.
PMID: 31395736
Free PMC article.